298 related articles for article (PubMed ID: 12935982)
1. The effect of common hematologic abnormalities on the ability of blood models to detect erythropoietin abuse by athletes.
Parisotto R; Ashenden MJ; Gore CJ; Sharpe K; Hopkins W; Hahn AG
Haematologica; 2003 Aug; 88(8):931-40. PubMed ID: 12935982
[TBL] [Abstract][Full Text] [Related]
2. Development of reference ranges in elite athletes for markers of altered erythropoiesis.
Sharpe K; Hopkins W; Emslie KR; Howe C; Trout GJ; Kazlauskas R; Ashenden MJ; Gore CJ; Parisotto R; Hahn AG
Haematologica; 2002 Dec; 87(12):1248-57. PubMed ID: 12495898
[TBL] [Abstract][Full Text] [Related]
3. Second-generation blood tests to detect erythropoietin abuse by athletes.
Gore CJ; Parisotto R; Ashenden MJ; Stray-Gundersen J; Sharpe K; Hopkins W; Emslie KR; Howe C; Trout GJ; Kazlauskas R; Hahn AG
Haematologica; 2003 Mar; 88(3):333-44. PubMed ID: 12651273
[TBL] [Abstract][Full Text] [Related]
4. Hematologic passport for athletes competing in endurance sports: a feasibility study.
Malcovati L; Pascutto C; Cazzola M
Haematologica; 2003 May; 88(5):570-81. PubMed ID: 12745277
[TBL] [Abstract][Full Text] [Related]
5. Effect of altitude on second-generation blood tests to detect erythropoietin abuse by athletes.
Ashenden MJ; Gore CJ; Parisotto R; Sharpe K; Hopkins WG; Hahn AG
Haematologica; 2003 Sep; 88(9):1053-62. PubMed ID: 12969814
[TBL] [Abstract][Full Text] [Related]
6. A third generation approach to detect erythropoietin abuse in athletes.
Sharpe K; Ashenden MJ; Schumacher YO
Haematologica; 2006 Mar; 91(3):356-63. PubMed ID: 16503554
[TBL] [Abstract][Full Text] [Related]
7. Detection of recombinant human erythropoietin abuse in athletes utilizing markers of altered erythropoiesis.
Parisotto R; Wu M; Ashenden MJ; Emslie KR; Gore CJ; Howe C; Kazlauskas R; Sharpe K; Trout GJ; Xie M
Haematologica; 2001 Feb; 86(2):128-37. PubMed ID: 11224480
[TBL] [Abstract][Full Text] [Related]
8. Reticulocyte parameters as potential discriminators of recombinant human erythropoietin abuse in elite athletes.
Parisotto R; Gore CJ; Hahn AG; Ashenden MJ; Olds TS; Martin DT; Pyne DB; Gawthorn K; Brugnara C
Int J Sports Med; 2000 Oct; 21(7):471-9. PubMed ID: 11071048
[TBL] [Abstract][Full Text] [Related]
9. Effect of pre-competition and altitude training on blood models used to detect erythropoietin abuse by athletes.
Ashenden MJ; Sharpe K; Schoch C; Schumacher YO
Haematologica; 2004 Aug; 89(8):1019-20. PubMed ID: 15339692
[TBL] [Abstract][Full Text] [Related]
10. Analysis of human reticulocyte genes reveals altered erythropoiesis: potential use to detect recombinant human erythropoietin doping.
Varlet-Marie E; Audran M; Lejeune M; Bonafoux B; Sicart MT; Marti J; Piquemal D; Commes T
Haematologica; 2004 Aug; 89(8):991-7. PubMed ID: 15339684
[TBL] [Abstract][Full Text] [Related]
11. Effect of physical fitness and endurance exercise on indirect biomarkers of recombinant erythropoietin misuse.
Abellan R; Ventura R; Pichini S; Palmi I; Bellver M; Olive R; Pacifici R; Pascual JA; Zuccaro P; Segura J
Int J Sports Med; 2007 Jan; 28(1):9-15. PubMed ID: 16804802
[TBL] [Abstract][Full Text] [Related]
12. The influence of exercise on serum markers of altered erythropoiesis and the indirect detection models of recombinant human erythropoietin abuse in athletes.
Schumacher YO; Temme J; Bueltermann D; Schmid A; Berg A
Haematologica; 2003 Jun; 88(6):712-4. PubMed ID: 12801849
[No Abstract] [Full Text] [Related]
13. Longitudinal variation of hemoglobin and reticulocytes in elite rowers.
Ashenden MJ; Lacoste A; Orhant E; Audran M; Sharpe K
Haematologica; 2004 Nov; 89(11):1403-4. PubMed ID: 15531469
[TBL] [Abstract][Full Text] [Related]
14. Comparison of hematologic data in world elite junior speed skaters and in non-athletic juniors.
Mayr A; Kuipers H; Falk M; Santer P; Wierer B
Int J Sports Med; 2006 Apr; 27(4):283-8. PubMed ID: 16572370
[TBL] [Abstract][Full Text] [Related]
15. Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity.
Bovy C; Gothot A; Delanaye P; Warling X; Krzesinski JM; Beguin Y
Nephrol Dial Transplant; 2007 Apr; 22(4):1156-62. PubMed ID: 17237481
[TBL] [Abstract][Full Text] [Related]
16. A novel method utilising markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes.
Parisotto R; Gore CJ; Emslie KR; Ashenden MJ; Brugnara C; Howe C; Martin DT; Trout GJ; Hahn AG
Haematologica; 2000 Jun; 85(6):564-72. PubMed ID: 10870111
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
[TBL] [Abstract][Full Text] [Related]
18. Haematocrit in elite athletes.
Vergouwen PC; Collée T; Marx JJ
Int J Sports Med; 1999 Nov; 20(8):538-41. PubMed ID: 10606218
[TBL] [Abstract][Full Text] [Related]
19. Hypochromic erythrocytes (%): a reliable marker for recognizing iron-restricted erythropoiesis and predicting response to erythropoietin in anemic patients with myeloma and lymphoma.
Katodritou E; Terpos E; Zervas K; Speletas M; Kapetanos D; Kartsios C; Verrou E; Banti A; Effraimidou S; Christakis J
Ann Hematol; 2007 May; 86(5):369-76. PubMed ID: 17375302
[TBL] [Abstract][Full Text] [Related]
20. Identification of blood erythroid markers useful in revealing erythropoietin abuse in athletes.
Magnani M; Corsi D; Bianchi M; Paiardini M; Galluzzi L; Gargiullo E; Parisi A; Pigozzi F
Blood Cells Mol Dis; 2001; 27(3):559-71. PubMed ID: 11355895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
